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Abstract: The preparation of vesicle from a mixture of linolenic acid and 1,2-
dipalmitoyl-sn-glycerol-3-phosphoethanolamine-N-[methoxy-(polyethylene glycol) 
-2000] (DPPE-PEG2000) has been successfully carried out by using dry lipid 
hydration method. The effect of pH on particle size, zeta potential, encapsulation 
efficiency and critical vesiculation concentration (CVC) of the prepared vesicle 
suspensions in aqueous were studied. Macroscopic stability of the vesicles was also 
evaluated through their particle size and zeta potential for a period of 30 days. We 
found that CVC vary according to the pH, with higher pH of the bulk solution, 
CVC is higher. Vesicles formed at pH 8.5 were the most stable suspension 
throughout a period of 30 days compared to those at pH 7.5 and pH 9.0. Addition 
of DPPE-PEG2000 into the preparation of vesicle at pH 8.5 caused a reduction of 
the vesicle size to the scale of nanometer which is an advantage to their application. 
On the other hand, encapsulation of calcein and vitamin E were carried out. Certain 
amount of these compounds could be successfully loaded into the resulting 
liposomes under this experimental condition. 
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Introduction 
Vesicles are bilayer spherical aggregates of amphiphilic molecules with the basic matters are 
commonly consisting of a hydrophilic head group and double hydrocarbon tailed such as 
phospholipid. Vesicles have long been used as a tool for the delivery of vaccines, enzymes 
and drugs in the body because it can direct a drug to the target. At the same time vesicles 
also act as a reservoir in release of the drug at a slower rate. Therefore healthy cells are 
shielded from the drug’s toxicity, especially at the vulnerable tissues such as kidneys and 
liver. In addition, vesicles are biocompatible, low risk of toxicity, commercially available 
and the preparation methods are not too complicated
1
.  
 Amphiphiles with single hydrocarbon tail such as fatty acids have also been used to 
prepared vesicles. Oleate-oleic acid vesicles were the first single chain fatty acid vesicle 
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successfully prepared by Gebicki and Hicks in 1973
2, 3
. Later, vesicles were also prepared 
from polyunsaturated fatty acid such as linoleic acid (cis,cis-9,12-octadecadienoic acid)
4,5
 
and cis-4,7,10,13,16,19-docosahexaenoic acid
6
. Besides, short chain saturated fatty acids 
such as octanoic acid and decanoic acid
7
 have also been reported to form vesicles 
successfully. 
 Fatty acids are selected instead of phospholipids because they are less expensive, easily 
hydrolyzed, simple molecular structure and present in the membrane naturally. However, the 
formation of fatty acid vesicles is restricted to certain range of pH, type of ionic composition 
in the buffer solution and concentration of the fatty acid
8
. For a solution at pH approximately 
to the pKa of the fatty acid, concentration ratio of the ionized to non-ionized fatty acid 
molecules are  1. Hence, pseudo-double-chain surfactant can be formed through hydrogen 
bonding where a proton from the non-ionized carboxylic acid is shared by the adjacent 
ionized carboxylated molecule that has the appropriate geometry to induce the formation of 
bilayer and hence vesicle.  
 Nevertheless, fatty acid vesicles encounter a challenge like other colloidal system which 
is stability. They are facing trouble on retain their physical particle size with no 
agglomeration or flocculation during time of storage. Environment of the fatty acid 
dispersing medium such as pH and ionic concentration play an important role in maintaining 
the stability of vesicle suspension. Hence, lots of works have been carried out in order to 
improve the stability of vesicles suspension.  
 One of the successful works that enhanced the stability of fatty acid vesicle was by 
extending the pH range of vesicle formation. In order to form vesicle in a more acidic region, 
addition of amphiphilic molecule with headgroup of sulphonate, sulphate or oligo(ethylene 
oxide) unit intercalated between the hydrocarbon chain and the carboxylate were found to be 
effective
9
. On the other hand, addition of long chain linear alcohol has successfully shifted 
the pH for vesicle formation towards alkaline region
10
. To our knowledge, no literature work 
has been reported regarding the effect of pH on PEGylated fatty acid vesicle solution. 
Although fatty acid vesicles can be formed in a narrow range of pH, evaluation on the 
physicochemical properties of the vesicles within that range of pH are still not clear. It is 
vital to open a new path way of application with additional information about the changes 
occurred as the pH change slightly although still within the pH range for vesicle formation. 
Another alternative that has been proven to enhance the stability of the vesicle is through 
steric stabilization by modifying the surface of the vesicle
11-13
. In this regard, a bulky 
hydrophilic head group is introduced to the vesicle. This can be done by incorporation of 
either natural or synthethic substances such as glycolipid, glycoprotein, polysaccharides, 
lectins and synthetic polymer. Nevertheless, less attention has been paid to the relevancy of 
synthetic polymer in stabilization of the fatty acid vesicle. 
 In the present study, investigation of pH effect on the stability of linolenate-linolenic 
acid vesicle was carried out through evaluation of the data from particle size and zeta 
potential over a storage period of 30 days. Furthermore, synthetic polymer covalently 
bonded to phospholipid; 1,2-dipalmitoyl-sn-glycerol-3-phosphoethanolamine-N-[methoxy 
(polyethylene glycol)-2000] (DPPE-PEG2000) was added to the formation of vesicle and 
the effect of this substance with respect to pH on the physicochemical properties of vesicle 
was also studied. The efficiency of vesicle to encapsulate water soluble and water insoluble 
materials will also be explored. 
 
Experimental 
Alpha-linolenic acid (cis,cis,cis- 9, 12, 15- octadecatrienoic acid) was from Sigma         
(St. Louis, USA) with purity ≥ 99.0%, 1,2-dipalmitoyl-sn-glycerol-3-phosphoethanol-
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amine-N-[methoxy(polyethylene glycol)-2000] (DPPE-PEG2000) sodium salt was 
purchased from Avanti polar lipids (Alabaster, AL), boric acid with minimum 99.5% 
was from Fluka (Buchs, Switzerland), hydrochloric acid, sodium hydroxide 98 % and 
chloroform (distilled) were from HmBG Chemicals, sodium dihydrogen phosphate 
dehydrate  99.0% and disodium hydrogen phosphate  98%, DL--tocopherol acetate 
~ 98% and calcein  93% were from Fluka. All chemicals were used as received. 
Deionized water with resistivity18.2 MΩ cm was obtained from Barnstead NANOpure® 
Diamond
TM
 ultrapure water system. Deionised water was doubly distilled and deaerated 
with dried nitrogen gas prior to use. 
Investigation of the effect of pH on vesicles’ size and zeta potential  
Preparation of stock solution 
A stock solution of 12.5 mM alpha-linolenic acid in 27.5 mM NaOH was prepared by 
mixing both chemicals. The solution was stirred until a transparent solution was obtained. 
Stock solution of alpha-linolenic acid containing DPPE-PEG2000 was prepared by first 
dissolving 12.5 mM alpha-linolenic acid and 0.25 mM DPPE-PEG2000 in 2 ml Chloroform. 
The mixture was then placed into a rotary evaporator at 40 °C to remove all of the 
chloroform. Warm distilled water at 50 °C and 27.5 mM NaOH solution were slowly added. 
The solution was then sonicated for 5 minutes.  
Acid-base titration of the stock solution with HCl (0.125 M) 
A stock solution of 1.500 mL was pipetted into a 14.5 ml sample vial followed by addition 
of (1.500 – x) mL deionised water and x mL HCl (0.125 M). The solution was mixed for 1 
minute by vortex mixer Uzusio VTX 3000L then the pH of the solution was measured by a 
Mettler Toledo pH meter. Calibration was performed at the titration temperature with buffer 
of pH 4.0, 7.0 and 9.2. An average of 3 measurements was carried out. A similar procedure 
was repeated for alpha-linolenic acid containing DPPE-PEG2000. 
Light microscopy observation 
The formations of vesicle in the solutions were observed with LEICA DMRXP Germany 
made light polarizing microscope. Images were focused by bright field and dark field mode 
between cross polarizers using oil immersion technique. This system consists of a high 
voltage beam source, a polarizing unit and a detector unit. The detector unit is interface with 
a personal computer equipped with image analysis software (Leica Qwin Standard version 
2.6) that helps capture and import images from the microscope.  
Transmission electron microscopy 
The vesicle images at 40 mM were obtained by using Hitachi H-7100 transmission electron 
microscope with the negative-staining method. The sample was prepared by immersed the 
formvar-coated copper grid into a drop of the vesicle solution and allowed to stand for           
10 minutes. The excess vesicle solution was blotted with filter paper and followed by 
staining process with 3% phosphotungstic acid. The grid was allowed to stand for another 10 
minutes and air dried. The specimens were viewed and photographed with a transmission 
electron microscope operating at accelerating voltage 100 kV. 
Particle size and zeta potential measurement 
The hydrodynamic size and zeta potential of the vesicles with various pHs were determined 
by dynamic light scattering (DLS) Malvern particle size analyzer, Model Nano ZS 
(Worcestershire, UK). All particle size and zeta potential measurements were made at the 
scattering angle of 175° and 17°, respectively. The measurements were carried out at 
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temperature of 30 °C. The mean value is obtained from three measurements. Similar method 
was applied on the evaluation of vesicles’ stability. 
Determinations of CVCs for alpha-linolenic acid solutions 
A series of solutions with various concentration of alpha-linolenic acid at pH 7.5, pH 8.5 and 
pH 9.0 were prepared. Borate buffer pH 8.5 or pH 9.0 of 50 mM after make up to the 
volume was added to the solution at desired pH. Similarly, 50 mM of phosphate buffer pH 
7.5 was used to prepare vesicle solution of pH 7.5. The solutions were then filtered by use of 
a 0.45 m nylon filter from (Minisart) prior to measurements. PEGylated vesicle solutions 
of alpha-linolenic acid containing DPPE-PEG2000 were prepared by the similar procedure. 
The CVC determinations were carried out at 30 °C employing du Nouÿ ring tensiometer 
balance from KRUSS with K12 tensiometer processor.  
Evaluation of stability 
Vesicle solutions with concentration of 2 mM at pH 7.5, pH 8.5 and pH 9.0 were prepared as 
mentioned in the determination of CVC and stored at 28 °C for a period of 30 days. 
Measurement of particle size and zeta potential for the vesicle solutions were carried out by 
using the similar method as stated above during that period of time. 
Encapsulation of calcein and vitamin E 
A mixture of 25 mM fatty acid and 0.5 mM calcein in chloroform was dried under a rotor 
evaporator at 40 C. Similarly, the PEGylated vesicle was prepared in the same manner but 
this time 0.5 mM of DPPE-PEG2000 was added. Warmed deionized water at 50 C was then 
slowly added to the dried lipid followed by addition of buffer solution at the desired pH with 
make up final concentration of 50 mM. The solution was then placed in a bath sonicator 
(JAC Ultrasonic 1505) at 30 C for 5 minutes. Similar method was applied for the 
encapsulation of vitamin E. The encapsulated and non-encapsulated substances were 
separated by using mini-column method
14
. Pretreatment of Sepharose 4B with mobile phase 
for swelling purpose was used as a stationery phase. A small piece of cotton was placed at 
the bottom of the barrel of a 5 mL plastic syringe prior to packing with Sepharose 4B in 
order to prevent leakage of sepharose 4B. Then the column was inserted into a centrifugal 
tube so that it was securely supported at the top of the test tube by the finger grips of the 
syringe. A volume of 50 L vesicle solution containing entrapped and free solute was 
applied to the Sepharose 4B bed followed by 3  0.5 mL of mobile phase. The column was 
spun at knob 4 for 2 minutes in an MSE centrifuge with swinging buckets. The first 
separation that comes out into the centrifugal tube was the encapsulated vesicle solution that 
latter was diluted to 5 mL with distilled ethanol. The remaining solute retained by the 
Sepharose was recovered by washing the column with the mobile phase and eluted by 
centrifugation at the similar speed for three times followed by dilution to 10 mL with 
distilled ethanol. Both solutions of encapsulated and non-encapsulated vitamin E were then 
analyzed using Shimadzu LC-20AT High Performance Liquid Chromatography coupled 
with SPD-20A prominence UV/Vis Detector. The isocratic mobile phase system composed 
mixture of all HPLC grade solvents; ethanol/methanol/acetonitrile (45:45:10 by volume) 
was delivered to the column at a flow rate of 1 mL min
-1
. A sample of 20 L was injected into 
the C18 reverse phase Purospher
 
Star column with dimension 4.6 mm  250 mm and the 
particle diameter of 5 m. The eluent was monitored at 287 nm, and the detector temperature 
was set at 25 °C. Analysis of calcein concentration was carried out by Cary 50 UV-Vis 
Spectrophotometer at 496 nm. The encapsulation efficiency was calculated from the percentage 
value of absorbance for encapsulated calcein at 496 nm or the area under peak at retention time 
9.2 min for encapsulated vitamin E over the absorbance or area for total amount of solute.  
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Results and Discussion 
The equilibrium titration curve of linolenic acid and PEGylated-linolenic acid as a function 
concentration HCl added is illustrated in Figure 1. A transparent solution composes of all 
ionized fatty acid molecules were observed at pH above 9.5. Further addition of HCl into the 
alkaline solution resulted in protonation of some anionic linolenate molecules. Hence, 
addition of HCl may increases the amount of non-ionized fatty acid molecules. The 
coexistence of ionized and non-ionized molecules in the solution leads to the formation of 
pseudo-double-chain surfactant between the head groups of COO
- 
and COOH via hydrogen 
bond. From our studies, linolenic acid is found to form vesicles in the pH range of solution 
from 7.5 to 9.0. As can be seen from figure 1, the pH of mixed fatty acid and DPPE-
PEG2000 is lower compared to solution with only fatty acid. The presence of DPPE-
PEG2000 with a long hydrophilic polyethylene glycol head group moiety would coat around 
the surface of spherical vesicle and hence promotes steric stabilization to the vesicles. It has 
also been agreed that PEG promotes the formation of vesicle and inhibits the aggregation of 
the vesicle through the long ethoxylate hydrophilic chains that extended out to at least 5 nm 
from the surface of bilayer
15,16
. This hydrophilic chain also plays a role in shielding the 
ionized fatty acid molecules from react with proton. As a result, concentration of free proton 
in the bulk solution is normally higher, therefore the pH is lowered. 
 
 
 
Figure 1. Equilibrium titration curve of linolenic acid (●) 12.5 mM and PEGylated linolenic 
acid (○) 12.5 mM at 28 °C as a function concentration HCl. 
 
 The mean particle size and zeta potential for both linolenate-linolenic acid vesicles and 
PEGylated linolenate-linolenic acid vesicles at pH range from 3.5 to 10.0 were displayed in 
figure 2 and figure 3, respectively. Both of the figures show a drastic change in particle size 
and zeta potential values at the pH region about 7.5 to 9.0. The addition of DPPE-PEG2000 
into linolenic acid promotes the formation of smaller size vesicles. Furthermore, the 
magnitude of zeta potential for mixture of DPPE-PEG2000-linolenate-linolenic acid vesicles 
was also significantly smaller than those of linolenate-linolenic acid vesicle solution.  
 A plausible explanation for the formation of smaller size vesicle with incorporation of 
DPPE-PEG2000 is due to the presence of long PEG chain that is more dynamic in an 
aqueous solution
17
. As a result, the effective head group area is larger with addition of 
DPPE-PEG2000 that lead to a smaller value of packing parameter compared to the packing 
parameter in vesicle composing only linolenate-linolenic acid. A smaller value of packing 
parameter that still within the value greater than 0.5 but smaller than 1 may favors the 
formation of particles with higher curvature which promote the molecules to pack tightly. 
p
H
 
[HCl], mol dm-3 
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Therefore, particle size for PEGylated linolenate-linolenic acid vesicle is smaller compared 
to linolenate-linolenic acid vesicles. This observation supports the theory of successful 
insertion of DPPE-PEG2000 into the bilayer of vesicle.  
 A further confirmation on insertion of DPPE-PEG2000 into the membrane bilayer was 
revealed from the measurement of zeta potential as indicated in Figure 3. The decrease in 
magnitude of zeta potential is due to the presence of long ethoxylate polymer chain in 
DPPE-PEG2000 that coated around the surface of vesicles and hidden the negatively charge 
underneath the polymer layer. As a consequence, the mobility of the vesicles was reduced 
and the zeta potential becomes less negative.  
 
  
Figure 2. Mean particle size of 12.5 mM 
linolenic acid (●) and 12.5 mM PEGylated 
linolenic acid (○) at various pH. 
 
Figure 3. Mean zeta potential of 12.5 mM 
linolenic acid (●) and 12.5 mM PEGylated 
linolenic acid (○) at various pH. 
 The presence of vesicle was authenticated by appearance of cross-maltese images that 
showing the lamellar structure of the spherical vesicle suspension using light polarizing 
micrograph. In fact, Figure 4 confirmed the formation of vesicles at pH 7.5, 8.5 and 9.0.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Polarizing micrograph of (1) linolenate-linolenic acid vesicle and (2) PEGylated 
linolenate-linolenic acid vesicle at pH (A) 7.5, (B) 8.5 and (C) 9.0. 
 
 In this regard, the minimal concentration of linolenic acid required to form stable 
membrane bilayer which is known as critical vesiculation concentration (CVC) was also 
determined via surface tension method. As indicated in Table 1, CVC of linolenic acid and 
PEGylated linolenic acid at pH 7.5 is the lowest with assumption that emulsion was not 
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formed. The formation of fatty acid vesicle is dominated as the ionized carboxylate and non-
ionized carboxylic are co-exist. As mentioned elsewhere, pKa of linolenic acid is 8.28
18
. 
Therefore, at pH approximately 8.28, concentration of linolenate and linolenic acid are 
almost equimolar and the formations of pseudo-double-chain surfactant via hydrogen bonds 
that can be analogue to phospholipid are encouraged. Thus, it leads to engender of bilayer 
vesicle. However, at the pH higher than pKa, CVC of the solution is the highest due to 
considerable increase amount of linolenate monomer in the solution. Thus at pH 9.0, the 
overall hydrophilicity in the solution is higher that results in a weaker driving force for self 
aggregation. As a consequence, higher amount of non-ionized linolenic acid is required and 
resulting in a higher CVC. In contrary, despite the amount of linolenate anion is less at pH 
7.5, the concentration of linolenic acid is sufficient for vesicle formation through the 
hydrophobic interactions and hydrogen bonds.  Similar trend was found for linolenic acid 
with incorporation of DPPE-PEG2000 where we observed CVC raised as pH increased. Yet, 
CVC for the solution of linolenate-linolenic acid with incorporation of DPPE-PEG2000 is 
found significantly different compared to the pure linolenate-linolenic acid solution. The 
result indicates that at pH 8.5 and pH 9.0, addition of DPPE-PEG2000 to linolenic acid 
increased the CVCs. In general, DPPE-PEG2000 with negatively charge causes an additional 
concentration of anion in the solution. Therefore, at pH 8.5 and pH 9.0, concentration of 
anion in the solution is higher compared to the non-ionized linolenic acid. In order to 
achieve the formation of vesicle, much more non-ionized linolenic acid molecule is required 
and this leads to an increase in CVC. In other words, addition of DPPE-PEG2000 
destabilized the formation of bilayer at pH 8.5 and pH 9.0. In contrast, CVC for linolenic 
acid-DPPE-PEG2000 solution at pH 7.5 is lower than CVC of linolenic acid. This can be 
explained by lower amount of linolenate anion is required due to the availability of anionic 
DPPE-PEG2000. The results obtained here are consistent with the findings reported by 
Charles et. al.. They found that formation of nonanoate-nonanoic acid vesicle was stabilized 
by addition of nonanol and reported a lower CVC (20 mM) compared to vesicle prepared 
from only nonanoic acid (85 mM)
10
.  
 
Table 1. Critical vesiculation concentration (CVC) of linolenate-linolenic acid vesicle and 
PEGylated linolenate-linolenic vesicle at various pH. 
pH 
Critical vesiculation concentration, mM 
Linolenic acid DPPE-PEG2000-linolenic acid 
7.5 0.24 0.15 
8.5 0.88 0.91 
9.0 1.23 1.48 
 
 A colloidal system is considered stable if the particles do not aggregate into clusters at a 
significant rate. As illustrated from Figure 5, mean particle size of linolenate-linolenic acid 
vesicles and vesicles consist of DPPE-PEG2000 at pH 7.5 increase gradually. The plausible 
explanation for this is due to the hydrophobic nature of the non-ionized linolenic acid. In 
contrast, it is observed from figure 6 that zeta potential becomes less negative for PEGylated 
vesicle with time. This phenomenon implicates the aggregation of vesicles which lead to 
slower mobility and thus the magnitude of zeta potential. Similarly, vesicles formed at pH 
9.0 from both pure linolenic acid and PEGylated lipid  mixed with  linolenic acid only manage 
manage to maintain their particle size for about 7 days. This is also revealed by a decrease in 
magnitude of the zeta potential. An important feature discovered from these results is DPPE-
PEG2000 did not play a significant role in stabilization of the vesicle suspension at pH 7.5 
and pH 9.0 as expected.  
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Figure 5. Mean particle size at pH 7.5        
(■, □), 8.5 (▲, △) and 9 (●, ○) of 
linolenate -linolenic acid vesicle (filled 
symbol) and PEGylated linolenate-linolenic 
acid vesicle (empty symbol). 
Figure 6. Mean zeta potential at pH 7.5  
(■, □), 8.5 (▲, △) and 9 (●, ○) of linolenate 
-linolenic acid vesicle (filled symbol) and 
PEGylated linolenate-linolenic acid vesicle 
(empty symbol). 
 
  
On the other hand, our results suggested that the most stable vesicle suspension can be 
formed at pH 8.5 as their mean vesicle size and zeta potential were almost consistent 
regardless the incorporation of DPPE-PEG2000. Nevertheless, it is observed that vesicles 
incorporated with DPPE-PEG2000 were smaller with particle size around 100 nm at pH 8.5. 
This might be due to the presence of bulky hydrophilic PEG chain at the bilayer surface 
promoting the molecules to pack tightly with higher curvature. Therefore, this has proven the 
effectiveness of DPPE-PEG2000 participates in the formation of vesicles as to enhance the 
stabilization of vesicle suspension in an aqueous solution. An additional transmission electron 
micrograph for linolenic acid and PEGlylated linolenic acid at pH 8.5 were shown in Figure 7.  
 
 
 
Figure 7. TEM micrograph of 40 Mm linolenate-linolenic acid vesicle (A) and PEGylated 
linolenate-linolenic acid vesicle (B) at pH 8.5. The presences of vesicles are indicated by the 
arrow. 
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 Since the stability of the vesicle has been identified, encapsulation of water soluble 
and water insoluble materials such as calcein for former and vitamin E for latter were also 
studied. From table 2, it is found that the encapsulation efficiency of vitamin E in the vesicle 
is at least 10-fold higher than the encapsulation efficiency of calcein under our experimental 
condition. One of the plausible explanations for this observation is due to hydrophobicity 
nature of vitamin E which shows higher preferences to be embedded in the membrane 
bilayer. In contrary, calcein is water soluble especially at high pH, so they have a higher 
tendency of escaping in to the bulk solution during the process of bilayer convolution. As a 
result, the entrapped calcein that attribute to the percent of loading may be either from 
calcein entrapped at the hydrophilic layer of the membrane or those within the multilamellar 
structure. This explains the low percentage of calcein encapsulation by the vesicles. Similar 
reason also applicable to the vesicles with insertion of DPPE-PEG2000.  
 As the pH increase, the encapsulation of vitamin E decrease. This could be due to 
higher surface polarity and stronger electron density at the head group that inhibit 
permeation of vitamin E into the membrane. On the other hand, the encapsulation efficiency 
of vitamin E in PEGylated vesicle was found lower than linolenic acid that probably due to 
their smaller particle size. In addition, another possible explanation is the number of 
lamellae is reduced with incorporation of PEG as reported by Belsito et al.
19
. Therefore, 
limited amount of vitamin E can be loaded into to bilayer.  
 
Table 2. Percentage encapsulation efficiency of linolenate-linolenic acid vesicle and 
PEGylated linolenate-linolenic acid vesicle at pH 7.5, 8.5 and 9.0. 
pH 
% Encapsulation Efficiency 
Vitamin E Calcein 
Linolenate-
linolenic acid 
vesicle 
PEGylated linolenate-
linolenic acid vesicle 
Linolenate-
linolenic acid 
vesicle 
PEGylated 
linolenate-linolenic 
acid vesicle 
7.5 83±5 65±5 0.3±0.1 0.9±0.4 
8.5 55±6 39±6 3.4±0.5 3.0±0.8 
9.0 45±4 32±6 2.3±0.3 2.5±0.9 
 
Conclusion 
Physico-chemical properties of linolenate-linolenic acid vesicle can be altered by pH and/or 
addition of DPPE-PEG2000. Although vesicles can only be formed at a narrow range of pH 
as reported elsewhere, their physico-chemical properties deviate significantly in that region. 
In general, CVC vary according to the pH, higher pH associated with higher CVC and vice 
versa. In this study, vesicles formed at pH 8.5 are the most stable suspension regardless the 
incorporation of DPPE-PEG2000. The incorporation of DPPE-PEG2000 in the preparation 
of vesicles at pH 8.5 promotes the formation of nano size particles that broaden their field of 
application. Moreover, the encapsulation efficiencies of calcein and vitamin E display 
encouraging values.  
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